TELA Bio, Inc. announced the appointment of Federica F. O’Brien to the company’s Board of Directors, bringing the company’s total number of directors to eight. Ms. O’Brien has also been appointed chairperson of the audit committee. Ms. O’Brien has over 25 years of executive financial and operational leadership roles in life sciences and technology companies. Ms. O’Brien has held senior executive and financial leadership roles at Complexa, Inc., Cerecor, Inc., Cervilenz, Inc., Cardiokine, Inc., and Barrier Therapeutics, Inc. Earlier in her career, Ms. O'Brien was Chief Financial Officer of Infonautics, Inc., a publicly-held technology-based company. Currently, Ms. O’Brien is President of CFO’Brien Consulting, LLC, for which she provides strategic and financial consulting services for life sciences companies. Ms. O'Brien began her career in professional service accounting firms, most recently at PricewaterhouseCoopers, where she was dedicated to emerging growth companies.